The store will not work correctly when cookies are disabled.
2,2,2-Trifluoro-N'-[(1R,2E,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-ylidene]acetohydrazide
ID: ALA4529177
PubChem CID: 155545247
Max Phase: Preclinical
Molecular Formula: C12H17F3N2O
Molecular Weight: 262.27
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)[C@@H]2CC[C@@]1(C)/C(=N/NC(=O)C(F)(F)F)C2
Standard InChI: InChI=1S/C12H17F3N2O/c1-10(2)7-4-5-11(10,3)8(6-7)16-17-9(18)12(13,14)15/h7H,4-6H2,1-3H3,(H,17,18)/b16-8+/t7-,11+/m1/s1
Standard InChI Key: QCSKVWVDKPUNRT-DZKBWBLDSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
6.9668 -9.6577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2103 -10.3428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2775 -10.0539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9668 -11.2426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2775 -10.8464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6519 -10.0539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6519 -10.8464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9668 -8.8653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0481 -10.0952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0770 -10.6524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9585 -12.0928 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
5.5702 -9.6447 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8621 -10.0526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1548 -9.6433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4467 -10.0513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1555 -8.8261 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7990 -10.4198 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.6453 -9.7443 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.3062 -10.8915 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 2 1 0
5 3 1 0
6 1 1 0
7 6 1 0
1 8 1 1
9 2 1 0
10 2 1 0
4 11 1 1
4 5 1 0
7 4 1 0
3 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
15 18 1 0
15 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 262.27 | Molecular Weight (Monoisotopic): 262.1293 | AlogP: 2.87 | #Rotatable Bonds: 1 |
Polar Surface Area: 41.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.74 | CX Basic pKa: 0.49 | CX LogP: 3.11 | CX LogD: 3.11 |
Aromatic Rings: ┄ | Heavy Atoms: 18 | QED Weighted: 0.73 | Np Likeness Score: 0.16 |
References
1. Kovaleva KS, Zubkov FI, Bormotov NI, Novikov RA, Dorovatovskii PV, Khrustalev VN, Gatilov YV, Zarubaev VV, Yarovaya OI, Shishkina LN, Salakhutdinov NF.. (2018) Synthesis of d-(+)-camphor-based N-acylhydrazones and their antiviral activity., 9 (12): [PMID:30746065] [10.1039/C8MD00442K] |